📅Offer Date: 11 Dec 2024 – 13 Dec 2024
Data sourced from BSE & NSE · Last updated
Sai Life Sciences Limited IPO was subscribed 10.26x in total when bidding closed on 13 Dec 2024, with 30.93x in the QIB category, 4.92x in NII, 1.37x in retail. The issue ran from 11 Dec 2024 to 13 Dec 2024 at a price band of ₹522.00–₹549.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (1.37x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 1,10,84,225 | 34,28,35,079 | 30.93x |
| NIIs | 83,13,168 | 4,09,00,787 | 4.92x |
| SNIIs (<10L) | 27,71,056 | 75,92,693 | 2.74x |
| BNIIs (>10L) | 55,42,113 | 3,32,52,678 | 6.00x |
| Retail | 1,93,97,392 | 2,65,74,427 | 1.37x |
| Total | 3,87,94,785 | 39,80,34,494 | 10.26x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 608.52 | 18821.65 | 30.93x |
| NIIs | 456.39 | 2245.45 | 4.92x |
| Retail | 1064.92 | 1458.94 | 1.37x |
| Total | 2129.83 | 22526.04 | 10.26x |
Values derived from share count × issue price (₹549.00)
Because Sai Life Sciences Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.